Journal
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume 38, Issue 7, Pages 1074-1084Publisher
WILEY
DOI: 10.1002/hed.24406
Keywords
cancer; tumor infiltrating lymphocytes; prognosis
Categories
Funding
- University of Michigan Head and Neck Specialized Program of Research Excellence [NIH/NCI P50CA097248, NIH/NIDCD T32 DC005356]
Ask authors/readers for more resources
Background. Because immune responses within the tumor microenvironment are important predictors of tumor biology, correlations of types of tumor infiltrating lymphocytes (TILs) with clinical outcomes were determined in 278 patients with head and neck squamous cell carcinoma (HNSCC). Methods. Infiltrating levels of CD4 (helper T cells), CD8 (cytotoxic/suppressor T cells), FoxP3 (regulatory T cells), CD68 (myeloid-derived suppressor cells,) and CD1a (Langerhans) cells were measured in tissue microarrays (TMAs). Cox models tested associations with patient outcomes after adjusting for all known prognostic factors. Median follow-up was 36.6 months. Results. Higher CD4 and CD8 TIL levels were associated with improved overall survival (OS; hazard ratio [HR] 50.77; 95% confidence interval [CI] 50.65-0.93; p=.005 and HR=0.77; 95% CI=0.64-0.94; p=.008, respectively), and relapse-free survival (RFS; p=.03 and .05, respectively). After controlling for prognostic factors, higher CD4 levels predicted improved OS and disease-specific survival (DSS; p=.003 and p=.004, respectively). Conclusion. The findings suggest that TILs are a significant independent prognostic factor for HNSCC that differ by treatment. (C) 2016 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available